HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -23.8% | -56.3% | +1,164.3% | -46.9% | -35.1% | -47.5% | +178.1% | +158.4% | +25.2% | -42.0% | -72.5% | +295.7% | -68.7% | +276.2% | -75.9% | +69.7% | +50.8% | +375.7% | +1,009.6% | -97.2% | -3,591.9% | – | -47.1% | -257.2% | – | +268.5% | -0.3% | |
| – | +1.9% | +0.6% | +98.8% | -12.3% | -14.7% | +13.9% | +1.1% | +4.3% | +23.5% | +3.9% | -24.2% | +4.9% | +1.0% | -17.9% | +25.0% | +33.5% | +36.4% | -12.4% | -6.9% | +3.5% | -6.1% | +6.6% | +17.2% | -1.0% | -5.5% | +2.2% | -7.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4,756.4% | -97.0% | -3,591.9% | – | -47.1% | -257.2% | – | +268.5% | -0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -22.8% | – | – | – | -54.6% | +129.4% | -82.6% | – | – | |
| – | – | +21.1% | +47.8% | +38.2% | -4.3% | +17.8% | -3.8% | +7.8% | +30.9% | -5.6% | -13.2% | +6.8% | +82.5% | +198.1% | +7.5% | +25.9% | +30.2% | -13.5% | -81.0% | +464.1% | -84.3% | -14.3% | +12.3% | +27.6% | -16.1% | +47.5% | -44.2% | |
| – | -20.7% | +4.3% | +87.5% | +31.1% | -13.6% | +19.6% | +8.2% | +7.6% | +36.6% | -15.5% | -7.3% | +3.9% | +70.9% | +5,491.5% | +11.4% | +5.1% | -55.7% | -65.9% | -90.6% | +345.4% | -79.7% | -9.4% | +12.4% | +16.8% | -13.4% | +18.6% | -43.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -47.6% | -262.1% | – | +281.6% | +0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +11.3% | +5.9% | -51.4% | -82.0% | +791.9% | -55.4% | +109.5% | -100.0% | – | – | – | – | – | |
| – | -30.4% | -300.0% | – | – | – | -81.5% | +525.1% | -147.9% | – | +19.3% | -136.0% | – | +267.7% | +107.2% | +9.0% | +5.5% | -54.6% | -129.4% | – | -58.2% | -345.9% | – | -47.6% | -262.1% | – | +281.6% | +0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +11.3% | +5.9% | -51.4% | -41.8% | -100.0% | -66.7% | -288,372,700.0% | – | – | – | – | – | – | |
| – | -30.4% | -300.0% | – | – | – | -81.5% | +525.1% | -147.9% | – | +19.3% | -136.0% | – | +267.7% | +107.2% | +9.0% | +5.5% | -54.6% | -129.4% | – | -58.2% | -345.9% | – | -47.6% | -262.1% | – | +281.6% | +0.3% | |
| – | -30.4% | -111.5% | – | – | – | -81.5% | +525.1% | -103.0% | – | +19.3% | -105.2% | – | +267.7% | +110.6% | +118.6% | +5.7% | -53.0% | -123.4% | – | -11.1% | -215.7% | – | -47.6% | -262.1% | – | +290.2% | -1.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.